Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Guidance Document - Human-Use Antiseptic Drugs (PDF Version - 1.2 MB) Contact name: NNHPD Client Service Unit July 31, 2019 Notice Application of the Guidance Document: Human-Use Antiseptic Drugs The Human-Use Antiseptic Drugs (HUAD) guidance document applies to professional and…
Guidance on terms and conditions for class II to IV medical devices Download in PDF format (630 KB, 18 pages) Organization: Health Canada Date published: April 1, 2026 On this page Purpose Introduction Scope and application Policy objectives and statements Note about guidance…
Draft guidance on human and veterinary drug submissions based on promising evidence and terms and conditions: Overview Overview About terms and conditions Before filing a submission Submission screening and review Labelling and advertising Post-market safety Compliance and…
Consultation: Draft guidance on human and veterinary drug submissions based on promising evidence and terms and conditions Current status: Open Opened on December 12, 2025 and will close on February 10, 2026 Health Canada is seeking feedback on the Draft guidance on human and…
Draft guidance on terms and conditions for human and veterinary drugs: Overview Overview About terms and conditions Terms and conditions letters Progress reporting Filing information and review Compliance and enforcement Download in PDF format (1,206 KB, 32 pages) Organization:…
Consultation: Draft guidance on terms and conditions for human and veterinary drugs Current status: Open Opened on December 12, 2025 and will close on February 10, 2026 Health Canada is seeking feedback on the Draft guidance on terms and conditions for human and veterinary drugs…
Guidance Document for Source Establishments - Reporting Adverse Reactions to Human Cells, Tissues and Organs 1. Introduction 1.1 Scope This guidance document provides source establishments with assistance on how to comply with adverse reaction reporting obligations under the Food…
Revised Guidance Document: Acetaminophen Labelling Standard (PDF Version - 224 KB) Contact: Natural and Non-prescription Health Products Directorate September 15, 2016 Notice Our file number: The final version of the Health Canada Revised Guidance Document - Acetaminophen…
About the Medical Dictionary for Regulatory Activities Health Canada is collaborating with our international partners on issues related to drug and medical device clinical trials, authorizations, risk assessments, and potential shortages. Learn about how we are engaging our…
Medical devices for COVID-19: Conducting a clinical trial Conducting a clinical trial List of authorized clinical trials On this page Clinical trials regulations Applying to conduct a clinical trial for COVID-19 purposes Clinical trial regulations Clinical trials, or…
Page 4251 sur 6399Affichage de 42501 à 42510 sur 63986
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
